🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalIreland HSE coverage for Wegovy — looking for input Page 3

Ireland HSE coverage for Wegovy — looking for input

roxy_nash Tue, Jun 25, 2024 at 9:11 PM 13 replies 2,056 viewsPage 3 of 3
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jun 30, 2024 at 12:49 PM#11
GenomicsKate said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

This is exactly what I could not find anywhere else. Adding it to my notes with a link back to this thread.

Last edited: Jun 30, 2024 at 3:49 PM
47 22NeuroNate, JessicaH_TX, KevinCompounds and 44 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Jul 1, 2024 at 12:19 PM#12

From the other side of the consultation, briefly.

roxy_nash said:
...compounded vs brand cost and coverage...

This debate comes up weekly and I think both sides have valid points:

Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable

Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility

My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.

46 21Dr.GutHealth, amsterdam_pete, LondonLisa and 43 others
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Jul 2, 2024 at 11:48 AM#13
LipidDoc_ATL said:
Steady state is the thing most people miss.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

45 20mia_MS2, LeilaHI, marcus_mpls and 42 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Jul 3, 2024 at 11:17 AM#14
roxy_nash said:
Denials are usually procedural rather than clinical, and the order that works reflects that.
roxy_nash said:
...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

  1. Document medical necessity (BMI, comorbidities, failed alternatives)
  2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
  3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
  4. Request peer-to-peer review between your doctor and the plan's medical director
  5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

44 19ben_calgary, patPC_UT, Dr.DermMIA and 41 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jul 4, 2024 at 10:45 AM#15

Moderator note: a couple of off-topic posts removed. No action needed from anybody.

Last edited: Jul 4, 2024 at 2:45 PM
43 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 40 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register